Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review
Contraception · 2025-05 · 145 · 110809
DOI: 10.1016/j.contraception.2024.110809 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Contraception, 2025-05. Verfasst von Rui Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry and Institute for Therapeutics Discovery and Development, College of Pharmacy, University of Minnesota, Minneapolis…. Hauptthemen laut MEDLINE: Retinoic Acid Receptor alpha, Contraceptive Agents, Male, Indazoles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry and Institute for Therapeutics Discovery and Development, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.
- Department of Genetics and Development, Columbia University Medical Center, New York, NY, United States; Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY, United States; T…
- Department of Medicinal Chemistry and Institute for Therapeutics Discovery and Development, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States. Electronic address: georg@umn.edu.
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute of Child Health and Human Development
Zitieren
APA
Shi, R., Wolgemuth, D. J., & Georg, G. I. (2025). Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review. Contraception, 145, 110809. https://doi.org/10.1016/j.contraception.2024.110809
Vancouver
Shi R, Wolgemuth DJ, Georg GI. Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review. Contraception. 2025;145:110809. doi:10.1016/j.contraception.2024.110809
BibTeX
@article{Shi2025,
author = {Shi, Rui and Wolgemuth, Debra J and Georg, Gunda I},
title = {Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review},
journal = {Contraception},
year = {2025},
volume = {145},
pages = {110809},
doi = {10.1016/j.contraception.2024.110809}
}
EUVIMED